Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-07

Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating umbilical cord-derived mesenchymal stem cells for aging-related low-grade inflammation; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cell Therapy (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Nguyen Ton Ngoc Huynh | Conditions: Inflammatory Disease, Aging Problems | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING